Identifícate
Grupos
Investigadores/as
Financiamento
Resultados
Linfomas
GLUN
Royal Adelaide Hospital
Adelaida, Australia
Estás en
Colaboracións
Royal Adelaide Hospital
Publicacións en colaboración con investigadores/as de Royal Adelaide Hospital (1)
2022
IBCL-249 Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results From a Phase I/II Study
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S387
Contactar
Aviso legal
Axuda
translate
gl
arrow_drop_down
translate
gl
arrow_drop_down
es
ca
eu
en
fr
de